Safety and Efficacy of the Bacteriophage Preparation, ShigActive™, in a Human Experimental Model of Shigellosis
Clinical trial NCT05182749 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05182749
- Sponsor
- Intralytix, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-23
- Primary completion
- 2024-12-09
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.